Corporate Advisory and Governance, Equity Capital Markets, Mergers and Acquisitions, Financial Services, International, Life Sciences, McR Private, Resources and Renewables, Start-ups and Emerging Businesses, State Government QLD, Technology, Media, and Telecommunications
Recognised for Capital Markets and Corporate M&A
Legal 500 Asia-Pacific
Assisting clients across a range of sectors, Ben brings his multi disciplinary expertise to the technology, financial services, industrials, resources and renewables, food and agribusiness, health and life sciences sectors. His clients include ASX listed and large unlisted public companies, small to large proprietary companies, and early-stage companies and startups.
Ben is also an integral member of the McR Private team, supporting our family office and private clients.
He advises clients across the capital raising lifecycle, from seed funding to IPO and secondary raisings, including placements, rights issues and share purchase plans. Leveraging his diverse expertise, he also works across regulated and unregulated mergers and acquisitions, including due diligence and deal implementation, and corporate reconstructions via court approved schemes of arrangement. Advising on IPOs for companies such as Wagners, Chimeric Therapeutics and OtherLevels as well as secondary capital raisings for Wagners, Imugene and Prescient Therapeutics, among many others, his breadth of transactional experience spans a diverse range of sectors and listing requirements.
As Head of Startups at McCullough Robertson, Ben is an active supporter of the startup community, providing mentoring and legal support to several of Queensland’s incubators and accelerators.
With knowledge spanning across corporate and governance, he acts as an advisor on directors’ duties and liabilities to ensure his clients meet their regulatory obligations including with ASIC and ASX.
Originally from the UK, Ben is also admitted as a lawyer in England and Wales.
ASIC launches ASX inquiry – Boardroom Takeaways
Former Irexchange executives in the sights for alleged misleading prospectus
Secondary Capital Raising: four key options and when to use them
Advising Vonex (ASX: VN8) on its acquisition by leading Australian VoIP provider, Maxo Telecommunications for an all-cash deal valued at $34.4 million, via a scheme implementation deed.
Advising Group 6 Metals (ASX: G6M) on various capital raising transactions, including placements, share purchase plans, debt funding and other equity fundraising up to $80 million.
Advising AVADA Group on its successful formation and subsequent acquisitions of Verifact Traffic, Arid to Oasis Traffic Solutions, Platinum Traffic Services, D&D Traffic Management, The Traffic Marshall, and Construct Traffic.
Advising on the $344 million sale to Aussie Broadband by scheme of arrangement, in addition to various capital raisings and prior acquisitions of Faktortel, Sanity, Spiderbox, Telarus, Access Digital Networks, Zintel Communications and Digital Sense Hosting.
Advising HRL Holdings Limited on its $82.2 million takeover bid by ALS Limited
Advising OneVue Holdings Limited (ASX:OVH) on its $115.2m sale to technology company, Iress Limited, by scheme of arrangement.
Advising RACQ on its merger with QT Mutual Bank, involving both a demutualisation and separate scheme of arrangement.
Advising Viralytics Limited on the $502 million acquisition by global pharmaceutical company, Merck, by scheme of arrangement and various secondary capital raisings totalling over $180 million.
